Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2007, Article ID 93462, 9 pages
http://dx.doi.org/10.1155/2007/93462
Research Article

Attenuated Disease in SIV-Infected Macaques Treated with a Monoclonal Antibody against FasL

1Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD 21201, USA
2Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA
3Department of Hematopathology, MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA
4Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan
5The Chemo-Sero Therapeutic Research Institute (Kaketsuken), Kumamoto 860-8568, Japan

Received 8 October 2007; Accepted 31 October 2007

Academic Editor: Ethan M. Shevach

Copyright © 2007 Maria S. Salvato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Ameisen and A. Capron, “Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis,” Immunology Today, vol. 12, no. 4, pp. 102–105, 1991. View at Publisher · View at Google Scholar
  2. H. Groux, G. Torpier, D. Monte, Y. Mouton, A. Capron, and J. C. Ameisen, “Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals,” Journal of Experimental Medicine, vol. 175, no. 2, pp. 331–340, 1992. View at Publisher · View at Google Scholar
  3. D. Kaplan and S. Sieg, “Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease,” Journal of Virology, vol. 72, no. 8, pp. 6279–6282, 1998. View at Google Scholar
  4. J. Estaquier, M. Tanaka, T. Suda, S. Nagata, P. Golstein, and J. C. Ameisen, “Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists,” Blood, vol. 87, no. 12, pp. 4959–4966, 1996. View at Google Scholar
  5. M. J. Lenardo, “Interleukin-2 programs mouse αβ T lymphocytes for apoptosis,” Nature, vol. 353, no. 6347, pp. 858–861, 1991. View at Publisher · View at Google Scholar
  6. S. Zhou, R. Ou, L. Huang, G. E. Price, and D. Moskophidis, “Differential tissue-specific regulation of antiviral CD8+ T-Cell immune responses during chronic viral infection,” Journal of Virology, vol. 78, no. 7, pp. 3578–3600, 2004. View at Publisher · View at Google Scholar
  7. A. J. Zajac, J. N. Blattman, K. Murali-Krishna et al., “Viral immune evasion due to persistence of activated T cells without effector function,” Journal of Experimental Medicine, vol. 188, no. 12, pp. 2205–2213, 1998. View at Publisher · View at Google Scholar
  8. M. O. Westendorp, R. Frank, C. Ochsenbauer et al., “Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120,” Nature, vol. 375, no. 6531, pp. 497–500, 1995. View at Publisher · View at Google Scholar
  9. J. Uchiyama, S. Kishi, H. Yagita, S. Matsuzaki, and Y. Koga, “Fas ligand-mediated depletion of CD4 and CD8 lymphocytes by monomeric HIV-1-gp120,” Archives of Virology, vol. 142, no. 9, pp. 1771–1785, 1997. View at Publisher · View at Google Scholar
  10. Y. Yang, B. Dong, P. R. Mittelstadt, H. Xiao, and J. D. Ashwell, “HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter,” Journal of Biological Chemistry, vol. 277, no. 22, pp. 19482–19487, 2002. View at Publisher · View at Google Scholar
  11. M. Lichtner, C. Maran~o´n, P.-O. Vidalain et al., “HIV Type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4+ T lymphocytes,” AIDS Research and Human Retroviruses, vol. 20, no. 2, pp. 175–182, 2004. View at Publisher · View at Google Scholar
  12. I. Jeremias, I. Herr, T. Boehler, and K.-M. Debatin, “TRAIL/Apo-2-ligand-induced apoptosis in human T cells,” European Journal of Immunology, vol. 28, no. 1, pp. 143–152, 1998. View at Publisher · View at Google Scholar
  13. Y. Yang, I. Tikhonov, T. J. Ruckwardt et al., “Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4+ cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism,” Journal of Virology, vol. 77, no. 12, pp. 6700–6708, 2003. View at Publisher · View at Google Scholar
  14. M. T. Esser, J. W. Bess Jr., K. Suryanarayana et al., “Partial activation and induction of apoptosis in CD4+ and CD8+ T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1,” Journal of Virology, vol. 75, no. 3, pp. 1152–1164, 2001. View at Publisher · View at Google Scholar
  15. S. Aquaro, S. Panti, M. C. Caroleo et al., “Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes,” Journal of Leukocyte Biology, vol. 68, no. 3, pp. 429–435, 2000. View at Google Scholar
  16. A. Algeciras-Schimnich, S. R. Vlahakis, A. Villasis-Keever et al., “CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells,” AIDS, vol. 16, no. 11, pp. 1467–1478, 2002. View at Publisher · View at Google Scholar
  17. C. B. Bäumler, T. Böhler, I. Herr, A. Benner, P. H. Krammer, and K.-M. Debatin, “Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children,” Blood, vol. 88, no. 5, pp. 1741–1746, 1996. View at Google Scholar
  18. A. D. Badley, J. A. McElhinny, P. J. Leibson, D. H. Lynch, M. R. Alderson, and C. V. Paya, “Upregulation of fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes,” Journal of Virology, vol. 70, no. 1, pp. 199–206, 1996. View at Google Scholar
  19. D. Mitra, “HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid,” Immunology, vol. 87, no. 4, pp. 581–585, 1996. View at Publisher · View at Google Scholar
  20. E. M. Sloand, N. S. Young, P. Kumar, F. F. Weichold, T. Sato, and J. P. Maciejewski, “Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication,” Blood, vol. 89, no. 4, pp. 1357–1363, 1997. View at Google Scholar
  21. N. Oyaizu, Y. Adachi, F. Hashimoto et al., “Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection,” Journal of Immunology, vol. 158, no. 5, pp. 2456–2463, 1997. View at Google Scholar
  22. V. Monceaux, J. Estaquier, M. Février et al., “Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS,” AIDS, vol. 17, no. 11, pp. 1585–1596, 2003. View at Publisher · View at Google Scholar
  23. C. Yin, M. S. Wu, C. D. Pauza, and M. S. Salvato, “High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression,” Journal of Virology, vol. 73, no. 5, pp. 3692–3701, 1999. View at Google Scholar
  24. T. Nisihara, Y. Ushio, H. Higuchi et al., “Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction,” Journal of Immunology, vol. 167, no. 6, pp. 3266–3275, 2001. View at Google Scholar
  25. D. A. Regier and R. C. Desrosiers, “The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus,” AIDS Research and Human Retroviruses, vol. 6, no. 11, pp. 1221–1231, 1990. View at Google Scholar
  26. P. Trivedi, D. Horejsh, S. B. Hinds et al., “Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia,” Journal of Virology, vol. 70, no. 10, pp. 6876–6883, 1996. View at Google Scholar
  27. K. K. Steger, M. Dykhuizen, J. L. Mitchen et al., “CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques?” Journal of Virology, vol. 72, no. 2, pp. 1600–1605, 1998. View at Google Scholar
  28. M. Dykhuizen, J. L. Mitchen, D. C. Montefiori et al., “Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression,” Journal of General Virology, vol. 79, no. 10, pp. 2461–2467, 1998. View at Google Scholar
  29. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer, “Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection,” Nature, vol. 434, no. 7037, pp. 1093–1097, 2005. View at Publisher · View at Google Scholar
  30. Q. Li, L. Dua, J. D. Estes et al., “Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells,” Nature, vol. 434, no. 7037, pp. 1148–1152, 2005. View at Publisher · View at Google Scholar
  31. T. H. Finkel, G. Tudor-Williams, N. K. Banda et al., “Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes,” Nature Medicine, vol. 1, pp. 129–134, 1995. View at Publisher · View at Google Scholar
  32. R. Geleziunas, W. Xu, K. Takeda, H. Ichijo, and W. C. Greene, “HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell,” Nature, vol. 410, no. 6830, pp. 834–838, 2001. View at Publisher · View at Google Scholar
  33. T. Ndolo, N. K. Dhillon, H. Nguyen, M. Guadalupe, M. Mudryj, and S. Dandekar, “Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle,” Journal of Virology, vol. 76, no. 8, pp. 3587–3595, 2002. View at Publisher · View at Google Scholar
  34. X.-N. Xu, G. R. Screaton, F. M. Gotch et al., “Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus- infected cells,” Journal of Experimental Medicine, vol. 186, no. 1, pp. 7–16, 1997. View at Publisher · View at Google Scholar
  35. F. Villinger, T. M. Folks, S. Lauro et al., “Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates,” Immunology Letters, vol. 51, no. 1-2, pp. 59–68, 1996. View at Publisher · View at Google Scholar
  36. P. N. Fultz, R. B. Stricker, H. M. McClure, D. C. Anderson, W. M. Switz er, and C. Horaist, “Humoral response to SIV/SMM infection in macaque and mangabey monkeys,” Journal of Acquired Immune Deficiency Syndromes, vol. 3, no. 4, pp. 319–329, 1990. View at Google Scholar
  37. V. M. Hirsch, “What can natural infection of African monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS?” AIDS Reviews, vol. 6, no. 1, pp. 40–53, 2004. View at Google Scholar
  38. B. Hurtrel, F. Petit, D. Arnoult, M. Muller-Trutwin, G. Silvestri, and J. Estaquier, “Apoptosis in SIV infection,” Cell Death and Differentiation, vol. 12, pp. 979–990, 2005. View at Publisher · View at Google Scholar
  39. P. J. Enders, C. Yin, F. Martini et al., “HIV-mediated ?s T cell depletion is specific for V?2+ cells expressing the J?1.2 segment,” AIDS Research and Human Retroviruses, vol. 19, no. 1, pp. 21–29, 2003. View at Publisher · View at Google Scholar
  40. J. K. Sandberg, N. M. Fast, and E. H. Palacios, “Selective loss of innate CD4+ Vα24 natural killer T cells in human immunodeficiency virus infection,” Journal of Virology, vol. 76, no. 15, pp. 7528–7534, 2002. View at Publisher · View at Google Scholar
  41. T. Brunner, R. J. Mogil, D. LaFace et al., “Cell autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas,” Nature, vol. 373, pp. 441–444, 1995. View at Publisher · View at Google Scholar
  42. J. Dhein, H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer, “Autocrine T-cell suicide mediated by APO-1/(Fas/CD95),” Nature, vol. 373, pp. 438–441, 1995. View at Publisher · View at Google Scholar
  43. S.-T. Ju, D. L. Panka, H. Cui et al., “Fas(CD95)/FasL interactions required for programmed cell death after T cell activation,” Nature, vol. 373, pp. 444–448, 1995. View at Publisher · View at Google Scholar
  44. M. R. Alderson, T. W. Tough, T. Davis-Smith et al., “Fas ligand mediates activation-induced cell death in human T lymphocytes,” Journal of Experimental Medicine, vol. 181, no. 1, pp. 71–77, 1995. View at Publisher · View at Google Scholar
  45. J. D. Lelièvre, F. Mammano, D. Arnoult et al., “A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells,” Cell Death and Differentiation, vol. 11, no. 9, pp. 1017–1027, 2004. View at Publisher · View at Google Scholar
  46. W. Stohl, D. Xu, G. C. Starling, P. Casali, and P. A. Kiener, “Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death,” Cellular Immunology, vol. 203, no. 1, pp. 1–11, 2000. View at Publisher · View at Google Scholar
  47. T. L. Rothstein, J. K. M. Wang, D. J. Panka et al., “Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells,” Nature, vol. 374, pp. 163–165, 1995. View at Publisher · View at Google Scholar
  48. C.-C. Tsai, P. Emau, J. C. Sun et al., “Post-exposure chemoprophlaxis (PECP) against SIV infection of macaques as a model for protection from HIV infection,” Journal of Medical Primatology, vol. 29, no. 3-4, pp. 248–258, 2000. View at Publisher · View at Google Scholar
  49. M. S. Smith, L. Foresman, G. J. Lopez et al., “Lasting effects of transient postinoculation tenofovir [9-R-(2-phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques,” Virology, vol. 277, no. 2, pp. 306–315, 2000. View at Publisher · View at Google Scholar
  50. M. Spring, C. Stahl-Hennig, N. Stolte et al., “Enhanced cellular immune response and reduced CD8+ lymphocyte apoptosis in acutely SIV-infected rhesus macaques after short-term antiretroviral treatment,” Virology, vol. 279, no. 1, pp. 221–232, 2001. View at Publisher · View at Google Scholar
  51. E. S. Rosenberg, M. Altfeld, S. H. Poon et al., “Immune control of HIV-1 after early treatment of acute infection,” Nature, vol. 407, no. 6803, pp. 523–526, 2000. View at Publisher · View at Google Scholar
  52. D. E. Kaufmann, M. Lichterfeld, M. Altfeld et al., “Limited durability of viral control following treated acute HIV infection,” PLoS Medicine, vol. 1, no. 2, p. e36, 2004. View at Publisher · View at Google Scholar
  53. C. D. Pilcher, S. A. Fiscus, T. Q. Nguyen et al., “Detection of acute infections during HIV testing in North Carolina,” New England Journal of Medicine, vol. 352, no. 18, pp. 1873–1883, 2005. View at Publisher · View at Google Scholar
  54. M. S. Salvato, P. Emau, M. Malkovsky, K. T. Schultz, E. Johnson, and C. D. Pauza, “Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus,” Journal of Medical Primatology, vol. 23, no. 2-3, pp. 125–130, 1994. View at Google Scholar
  55. N. Kayagaki, A. Kawasaki, T. Ebata et al., “Metalloproteinase-mediated release of human Fas ligand,” Journal of Experimental Medicine, vol. 182, no. 6, pp. 1777–1783, 1995. View at Publisher · View at Google Scholar
  56. H. Lecoeur, E. Ledru, M.-C. Prévost, and M.-L. Gougeon, “Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods,” Journal of Immunological Methods, vol. 209, no. 2, pp. 111–123, 1997. View at Publisher · View at Google Scholar